Compounded Tirzepatide

Compounded tirzepatide is a GLP-1 treatment made with the same active ingredient as Mounjaro®, compounded here in the Philippines by a licensed partner pharmacy, at a fraction of the branded price. Losing weight was never about willpower, it's biology. Tirzepatide activates two hormones your body already makes, GLP-1 and GIP, so your appetite quiets. And because it's compounded, your dose is personalized to you, guided by a licensed Filipino doctor.

One small dose a week, and that's it. No clinic visits. No pharmacy queues. No explaining yourself at a counter. Your treatment arrives with everything you need and a step-by-step guide. You inject once weekly with a very small needle, and most people say they barely feel it. You start low, then you and your &you doctor adjust gradually, at your body's pace, until you find the dose that moves you toward your goal. The whole thing happens from your phone.

- Weeks 1 to 4: 2.5 mg weekly - Weeks 5 to 8: 5 mg weekly - Weeks 9 to 12: 7.5 mg weekly - Weeks 13 to 16: 10 mg weekly - Weeks 17 to 20: 12.5 mg weekly - Week 21 and on: 15 mg weekly This is the schedule your assessment suggests — not a prescription. Your &you doctor reviews it before anything is dispensed, and adjusts the dose and the pace to how your body responds.

Imagine a few weeks from now: the cravings that used to run your day have faded into the background. Many patients notice their appetite quieting within the first 2 to 4 weeks. In clinical trials of tirzepatide (the active ingredient in Mounjaro®), people lost up to around 22.5% of their body weight on average over about 72 weeks alongside diet and exercise. Real weight loss typically follows between weeks 8 and 12, and because you build up gradually, it's progress your body can actually hold onto, not another cycle you'll lose next month. Results vary from person to person, and your doctor tracks yours and adjusts as you go.

Some people don't feel anything, others feel it briefly: nausea, diarrhea, constipation, or stomach discomfort. These are usually mild to moderate and tend to fade as your body adjusts, which is exactly why your dose goes up slowly instead of all at once. And you're never left to figure it out alone. If anything feels off, your &you doctor is a message away, consultations included.

Do not use Compounded Tirzepatide if you: - Have a personal or family history of medullary thyroid carcinoma (MTC). - Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). - Are allergic to tirzepatide or any of its ingredients. If you’re unsure about your medical history, consult your healthcare provider before starting this treatment.

- Keep it in the fridge at 2–8°C until you start using it. Do not freeze it — a pen or vial that has frozen must be thrown away. - Keep away from light and out of reach of children. - Once you have started a pen or vial, check its label for how long it may stay at room temperature, and do not use it beyond that. - Do not use it if the liquid is cloudy, coloured or has particles in it.

A mandatory doctor consultation is required before starting treatment. During the consultation, you will receive training from our doctor and detailed usage information to ensure you can safely prepare your dose for self-administration. Our weight loss medications are intended for patients with a BMI ≥30 kg/m² or ≥27 with at least one weight-related comorbidity. Patients with type 1 diabetes are not eligible for treatment. You may use our BMI calculator to check your eligibility or consult our doctors to determine suitability for treatment. Please note that the vial is intentionally not full, but contains the exact amount personally prescribed by our doctors for each patient. Our tirzepatide is compounded by a licensed pharmacy. It is not FDA-approved and is prescribed case-by-case when appropriate; use only under clinician supervision.